Trastuzumab emtansine 100 mg powder for solution for infusion and/or injection vial 1209070003
SNOMED CT code
| SNOMED code | 1209070003 |
|---|---|
| name | Trastuzumab emtansine 100 mg powder for solution for infusion and/or injection vial |
| status | active |
| date introduced | 2022-05-31 |
| fully specified name(s) | Product containing precisely trastuzumab emtansine 100 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
| synonyms | Trastuzumab emtansine 100 mg powder for solution for infusion and/or injection vial |
| attributes - group0 | |
| Has manufactured dose form | Powder for solution for infusion and/or injection 1209021002 |
| Has unit of presentation | Vial 733026001 |
| Plays role | Antineoplastic therapeutic role 773879000 |
| attributes - group1 | |
| Has precise active ingredient | Trastuzumab emtansine 702836004 |
| Has BoSS | Trastuzumab emtansine 702836004 |
| Has presentation strength numerator unit | mg 258684004 |
| Has presentation strength denominator unit | Vial 733026001 |
| parents | Trastuzumab emtansine only product in parenteral dose form 896755007 |
| children |
|
| hierarchies | a selection of possible paths SNOMED CT Concept 138875005Pharmaceutical / biologic product 373873005 Medicinal product 763158003 Product manufactured as parenteral dose form 440132002 Trastuzumab emtansine-containing product in parenteral dose form 896754006 Trastuzumab emtansine only product in parenteral dose form 896755007 Trastuzumab emtansine 100 mg powder for solution for infusion and/or injection vial 1209070003 |
| ancestors | sorted most to least specific
|
| cpt crosswalks | |
Thank you for choosing Find-A-Code, please Sign In to remove ads.
Quick, Current, Complete - www.findacode.com